Search - tctmd.com

Displaying 1 - 20 of 309

Sort: Relevancy | Date

News Conference News ACC 2026

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

L.A. McKeown

April 02, 2026

News Industry News

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

March 30, 2026

Presentation TCT 2025

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Presentation TCT 2025

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Presenter: Ulf Teichgräber

October 26, 2025

Presentation TCT 2025

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Presenter: Osamu Iida

October 26, 2025

Presentation TCT 2025

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

Presenter: Seung-Whan Lee

October 26, 2025

Presentation TCT 2025

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

Presenter: Yuki Sakamoto

October 26, 2025

Presentation TCT 2025

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

Presenter: YUKI SHIMA

October 26, 2025

Presentation TCT 2025

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

Presenter: Jonghu Shin

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Presenter: Ramon L. Varcoe

October 26, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Presentation TCT 2024

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Presenter: Seung-Jun Lee

October 28, 2024

Presentation TCT 2024

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

Presenter: Jae Young Jeung

October 28, 2024

Presentation TCT 2024

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Advertisement

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TCT 908: Does Atherectomy Add Value to Femoropopliteal Intervention? A Comparative Analysis from the XLPAD Registry

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

TCT 459: Prognostic impact of optical frequency domain imaging findings in drug-coated balloon treatment for femoropopliteal lesions: Insight from the OCEAN-DCB study

TCT 209: Predictors of Restenosis After Drug-Coated Balloon Angioplasty for Femoropopliteal Chronic Occlusion Lesions

TCT 460: Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Treatment of Femoropopliteal Disease with a Novel Sirolimus-Eluting BRS: First-In-Human Results of the EFEMORAL I Trial

Top Endovascular News of 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

What’s Going to Be Big at TCT 2024?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content